Celltrion Strives to Lure Global Healthcare Firms to Songdo Biocluster

Celltrion said that it will go all out to help attract global bio-healthcare companies to the biocluster in Songdo, Incheon.

Celltrion works hard to attract global biopharmaceutical companies that develop raw and subsidiary materials to the Songdo Biocluster, west of Seoul. (Celltrion)

Last month, the company signed a business agreement with Sartorius, a global biopharmaceutical company, which decided to build a raw and subsidiary material manufacturing facility in Songdo.

Celltrion is also discussing with various other healthcare companies, such as Thermofisher Scientific, Avantor, and Cytiva, to attract their manufacturing and service supply facilities to the biocluster west of Seoul.

According to Celltrion, Thermofisher Scientific, a U.S. healthcare company, is considering building a manufacturing facility and distribution center in Korea. Avanator, another U.S.-based company that supplies products and services in life sciences, chemicals, and advanced materials, is also considering an investment in building production facilities in this country.

Cytiva, which supplies major raw and subsidiary materials for Celltrion's commercialized medicines, plans to make additional investments in the Songdo area after its recent spinoff from GE Healthcare. The company established an APAC Fast Track Center in Songdo in 2016 to provide process optimization services of biopharmaceutical production and process-related training.

"Local bio companies are likely to receive a more stable supply of important raw and subsidiary materials and services when global material companies invest in various manufacturing facilities and distribution warehouses in the Songdo Biocluster," a Celltrion official said.

The official added if core raw materials are jointly developed and supplied, and suppliers and users develop customized training programs to nurture specialists, it will create a synergy for both global suppliers and local biopharmaceutical manufacturers. Such a steady supply of materials is important as the demand for raw and subsidiary materials is exploding due to the ongoing global Covid-19 epidemic.

"We will operate a two-track system where we will discover local raw and subsidiary material makers with technological power and actively support them while attracting the manufacturing facilities of global companies to lower our dependence on imported products," the official said.